Symbols / NXL
NXL Chart
About
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 10.52M |
| Enterprise Value | 4.79M | Income | -8.68M | Sales | 156.93K |
| Book/sh | 0.26 | Cash/sh | 0.23 | Dividend Yield | — |
| Payout | 0.00% | Employees | 6 | IPO | — |
| P/E | — | Forward P/E | -1.45 | PEG | — |
| P/S | 67.01 | P/B | 2.15 | P/C | — |
| EV/EBITDA | -0.54 | EV/Sales | 30.50 | Quick Ratio | 12.20 |
| Current Ratio | 13.47 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.65 | EPS next Y | -0.39 | EPS Growth | — |
| Revenue Growth | -49.60% | Earnings | 2025-11-14 10:00 | ROA | -106.58% |
| ROE | -178.46% | ROIC | — | Gross Margin | 69.52% |
| Oper. Margin | -129.24% | Profit Margin | 0.00% | Shs Outstand | 18.65M |
| Shs Float | 15.93M | Short Float | 0.91% | Short Ratio | 1.08 |
| Short Interest | — | 52W High | 3.03 | 52W Low | 0.37 |
| Beta | 4.00 | Avg Volume | 277.15K | Volume | 3.06M |
| Target Price | $4.00 | Recom | None | Prev Close | $0.49 |
| Price | $0.56 | Change | 15.06% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$4.00
Mean price target
2. Current target
$0.56
Latest analyst target
3. DCF / Fair value
$-1.78
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.56
Low
$4.00
High
$4.00
Mean
$4.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-03-24 | up | Maxim Group | Hold → Buy | $5 |
| 2024-12-05 | down | Maxim Group | Buy → Hold | — |
| 2024-10-09 | init | Maxim Group | — → Buy | $3 |
News
RSS: Latest NXL news- Drug-free insomnia device trial targets 30 million adults - Stock Titan ue, 24 Feb 2026 13
- EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia - Bitget ue, 24 Feb 2026 12
- Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance Fri, 10 Oct 2025 07
- Congress boosts brain stimulation research for veterans, with Nexalin involved - Stock Titan Mon, 23 Feb 2026 13
- Nexalin Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis Sat, 20 Dec 2025 08
- Nexalin Technology stock rises after launching AI-powered virtual clinic - Investing.com hu, 05 Feb 2026 08
- Why are ASX 300 tech stock Nuix shares jumping 27% in Monday’s falling market? - The Motley Fool Australia Mon, 23 Feb 2026 00
- When Should You Buy Nuix Limited (ASX:NXL)? - Yahoo Finance Sun, 10 Aug 2025 07
- Nexalin stock soars after Alzheimer’s treatment shows cognitive benefits - Investing.com Wed, 08 Oct 2025 07
- 40‑Hz 15mA DIFS improves cognition: Nexalin's Gen‑2 SYNC shows fMRI connectivity gains in mild AD - Stock Titan Wed, 08 Oct 2025 07
- There Are Reasons To Feel Uneasy About Nuix's (ASX:NXL) Returns On Capital - Yahoo Finance ue, 16 Sep 2025 07
- Nexalin Technology expands at-the-market offering to $10 million - Investing.com Wed, 15 Oct 2025 07
- Home-based brain therapy: Nexalin, UCSD roll out AI virtual clinic - Stock Titan hu, 05 Feb 2026 08
- Nuix (ASX:NXL): Valuation Insights as AI and SaaS Transform the Tech Leader - Yahoo Finance hu, 09 Oct 2025 07
- Oct 22 Attendance — Nexalin at Maxim Growth Summit to Showcase DIFS Neurostimulation & Clinical Data - Stock Titan Fri, 10 Oct 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 83333 | — | — | Stock Award(Grant) at price 0.00 per share. | OSSER LEONARD A | Beneficial Owner of more than 10% of a Class of Security | — | 2025-09-29 00:00:00 | I |
| 1 | 36459 | — | — | Stock Award(Grant) at price 0.00 per share. | HU BENJAMIN | Director | — | 2025-09-29 00:00:00 | D |
| 2 | 36459 | — | — | Stock Award(Grant) at price 0.00 per share. | OWENS DAVID | Officer and Director | — | 2025-09-29 00:00:00 | D |
| 3 | 36459 | — | — | Stock Award(Grant) at price 0.00 per share. | KAZDEN ALAN | Director | — | 2025-09-29 00:00:00 | I |
| 4 | 6000 | 13200 | — | Purchase at price 2.20 per share. | SHELTON CAROLYN HAMBY | Officer | — | 2025-03-12 00:00:00 | I |
| 5 | 1000 | 2980 | — | Purchase at price 2.98 per share. | OWENS DAVID | Officer and Director | — | 2025-02-04 00:00:00 | D |
| 6 | 1000 | 3100 | — | Purchase at price 3.10 per share. | OWENS DAVID | Officer and Director | — | 2025-02-04 00:00:00 | D |
| 7 | 1500 | 4050 | — | Purchase at price 2.70 per share. | OWENS DAVID | Officer and Director | — | 2025-01-28 00:00:00 | D |
| 8 | 3000 | 7700 | — | Purchase at price 2.50 - 2.70 per share. | OWENS DAVID | Officer and Director | — | 2025-01-23 00:00:00 | D |
| 9 | 1000 | 2750 | — | Purchase at price 2.75 per share. | OWENS DAVID | Officer and Director | — | 2024-12-20 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -7.87M | -6.54M | -1.86M | -6.02M |
| TotalUnusualItems | 130.11K | 846.88K | 22.92K | 22.92K |
| TotalUnusualItemsExcludingGoodwill | 130.11K | 846.88K | 22.92K | 22.92K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -7.61M | -4.65M | -1.70M | -6.08M |
| ReconciledDepreciation | 15.11K | 4.25K | 535.00 | 537.00 |
| ReconciledCostOfRevenue | 36.59K | 25.69K | 363.21K | 21.44K |
| EBITDA | -7.74M | -5.69M | -1.83M | -6.00M |
| EBIT | -7.75M | -5.70M | -1.83M | -6.00M |
| NetInterestIncome | 3.19K | -38.84K | -59.38K | -82.32K |
| InterestExpense | 59.38K | 82.32K | ||
| NormalizedIncome | -7.74M | -5.50M | -1.72M | -6.10M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -7.61M | -4.65M | -1.70M | -6.08M |
| TotalExpenses | 7.92M | 5.81M | 3.15M | 6.16M |
| TotalOperatingIncomeAsReported | -7.75M | -5.70M | -1.83M | -6.02M |
| DilutedAverageShares | 9.22M | 7.36M | 5.57M | 4.90M |
| BasicAverageShares | 9.22M | 7.36M | 5.57M | 4.90M |
| DilutedEPS | -0.83 | -0.63 | -0.30 | -1.24 |
| BasicEPS | -0.83 | -0.63 | -0.30 | -1.24 |
| DilutedNIAvailtoComStockholders | -7.61M | -4.65M | -1.70M | -6.08M |
| NetIncomeCommonStockholders | -7.61M | -4.65M | -1.70M | -6.08M |
| NetIncome | -7.61M | -4.65M | -1.70M | -6.08M |
| NetIncomeIncludingNoncontrollingInterests | -7.61M | -4.65M | -1.70M | -6.08M |
| NetIncomeContinuousOperations | -7.61M | -4.65M | -1.70M | -6.08M |
| EarningsFromEquityInterestNetOfTax | 4.85K | 0.00 | ||
| TaxProvision | 0.00 | 0.00 | ||
| PretaxIncome | -7.61M | -4.65M | -1.70M | -6.08M |
| OtherIncomeExpense | 139.42K | 1.09M | 194.60K | 22.92K |
| OtherNonOperatingIncomeExpenses | 9.31K | 239.54K | 171.68K | |
| SpecialIncomeCharges | 0.00 | 615.00K | 22.92K | 22.92K |
| OtherSpecialCharges | -615.00K | -22.92K | -22.92K | |
| ImpairmentOfCapitalAssets | 0.00 | |||
| GainOnSaleOfSecurity | 130.11K | 231.88K | ||
| NetNonOperatingInterestIncomeExpense | 3.19K | -38.84K | -59.38K | -82.32K |
| TotalOtherFinanceCost | -3.19K | 38.84K | 59.38K | |
| InterestExpenseNonOperating | 59.38K | 82.32K | ||
| OperatingIncome | -7.75M | -5.70M | -1.83M | -6.02M |
| OperatingExpense | 7.89M | 5.78M | 2.79M | 6.14M |
| ResearchAndDevelopment | 1.19M | 1.92M | ||
| SellingGeneralAndAdministration | 6.70M | 3.86M | 2.79M | 6.14M |
| GeneralAndAdministrativeExpense | 6.70M | 3.86M | 2.79M | 6.14M |
| OtherGandA | 5.20M | 2.47M | 2.10M | 5.91M |
| SalariesAndWages | 1.50M | 1.39M | 694.11K | 228.74K |
| GrossProfit | 132.13K | 85.06K | 958.14K | 122.62K |
| CostOfRevenue | 36.59K | 25.69K | 363.21K | 21.44K |
| TotalRevenue | 168.72K | 110.75K | 1.32M | 144.06K |
| OperatingRevenue | 162.83K | 109.38K | 1.29M | 143.13K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 13.30M | 7.44M | 7.29M | 6.46M |
| ShareIssued | 13.30M | 7.44M | 7.29M | 6.46M |
| NetDebt | 537.26K | 98.34K | ||
| TotalDebt | 0.00 | 4.46K | 755.26K | 850.05K |
| TangibleBookValue | 3.42M | 3.10M | 5.48M | -1.68M |
| InvestedCapital | 3.68M | 3.21M | 6.18M | -921.83K |
| WorkingCapital | 3.41M | 3.00M | 5.48M | -1.61M |
| NetTangibleAssets | 3.42M | 3.10M | 5.48M | -1.68M |
| CapitalLeaseObligations | 0.00 | 4.46K | 55.26K | 89.93K |
| CommonStockEquity | 3.68M | 3.21M | 5.48M | -1.68M |
| TotalCapitalization | 3.68M | 3.21M | 5.48M | -1.66M |
| TotalEquityGrossMinorityInterest | 3.68M | 3.21M | 5.48M | -1.68M |
| StockholdersEquity | 3.68M | 3.21M | 5.48M | -1.68M |
| GainsLossesNotAffectingRetainedEarnings | -513.00 | -405.00 | 36.31K | 0.00 |
| OtherEquityAdjustments | -513.00 | -405.00 | 36.31K | |
| RetainedEarnings | -84.65M | -77.04M | -72.39M | -70.69M |
| AdditionalPaidInCapital | 88.31M | 80.24M | 77.82M | 69.00M |
| CapitalStock | 13.30K | 7.44K | 7.29K | 4.88K |
| CommonStock | 13.30K | 7.44K | 7.29K | 4.88K |
| TotalLiabilitiesNetMinorityInterest | 546.69K | 425.28K | 1.95M | 2.44M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 0.00 | 4.46K | 72.00K |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 4.46K | 72.00K | |
| LongTermCapitalLeaseObligation | 0.00 | 4.46K | 49.09K | |
| LongTermDebt | 22.92K | |||
| CurrentLiabilities | 546.69K | 425.28K | 1.95M | 2.36M |
| CurrentDeferredLiabilities | 0.00 | 130.00K | ||
| CurrentDeferredRevenue | 0.00 | 130.00K | ||
| CurrentDebtAndCapitalLeaseObligation | 4.46K | 750.80K | 778.04K | |
| CurrentCapitalLeaseObligation | 0.00 | 4.46K | 50.80K | 40.84K |
| CurrentDebt | 700.00K | 737.20K | ||
| OtherCurrentBorrowings | 200.00K | 237.20K | ||
| CurrentNotesPayable | 0.00 | 500.00K | 500.00K | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 240.00K | 150.00K | 0.00 | |
| PayablesAndAccruedExpenses | 306.69K | 270.82K | 1.20M | 1.46M |
| CurrentAccruedExpenses | 150.75K | 111.28K | 539.82K | 611.79K |
| InterestPayable | 0.00 | 111.50K | 232.95K | |
| Payables | 155.95K | 159.53K | 658.37K | 843.79K |
| AccountsPayable | 155.95K | 159.53K | 658.37K | 843.79K |
| TotalAssets | 4.22M | 3.63M | 7.43M | 753.70K |
| TotalNonCurrentAssets | 261.59K | 202.02K | 6.67K | 1.04K |
| InvestmentsAndAdvances | 864.00 | 96.00K | 0.00 | |
| InvestmentinFinancialAssets | 96.00K | 0.00 | ||
| AvailableForSaleSecurities | 96.00K | |||
| LongTermEquityInvestment | 864.00 | 96.00K | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 260.73K | 105.53K | 0.00 | |
| OtherIntangibleAssets | 260.73K | 105.53K | ||
| NetPPE | 0.00 | 496.00 | 6.67K | 1.04K |
| AccumulatedDepreciation | -2.68K | -2.18K | -29.86K | |
| GrossPPE | 0.00 | 496.00 | 8.86K | 30.90K |
| OtherProperties | 496.00 | 8.86K | 30.90K | |
| MachineryFurnitureEquipment | 30.90K | |||
| CurrentAssets | 3.96M | 3.43M | 7.43M | 752.66K |
| OtherCurrentAssets | 293.60K | 315.67K | 272.28K | 43.17K |
| PrepaidAssets | 43.17K | |||
| Inventory | 174.58K | 156.42K | 154.37K | 31.41K |
| Receivables | 13.04K | 9.37K | 4.88K | 16.30K |
| AccountsReceivable | 13.04K | 9.37K | 4.88K | 16.30K |
| CashCashEquivalentsAndShortTermInvestments | 3.48M | 2.95M | 6.99M | 661.78K |
| OtherShortTermInvestments | 2.91M | 2.37M | 6.83M | 0.00 |
| CashAndCashEquivalents | 574.49K | 580.23K | 162.74K | 661.78K |
| CashFinancial | 661.78K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -4.11M | -3.94M | -2.22M | -1.08M |
| RepaymentOfDebt | 0.00 | -200.00K | -37.20K | -9.60K |
| IssuanceOfDebt | 0.00 | 200.00K | ||
| IssuanceOfCapitalStock | 4.52M | 0.00 | 8.55M | 1.43M |
| CapitalExpenditure | -170.31K | -109.28K | ||
| InterestPaidSupplementalData | 0.00 | |||
| EndCashPosition | 574.49K | 580.23K | 162.74K | 661.78K |
| BeginningCashPosition | 580.23K | 162.74K | 661.78K | 78.44K |
| ChangesInCash | -5.75K | 417.49K | -499.04K | 583.34K |
| FinancingCashFlow | 4.52M | -200.00K | 8.51M | 1.66M |
| CashFlowFromContinuingFinancingActivities | 4.52M | -200.00K | 8.51M | 1.66M |
| ProceedsFromStockOptionExercised | 0.00 | 3.47K | 35.97K | |
| NetCommonStockIssuance | 4.52M | 0.00 | 8.55M | 1.43M |
| CommonStockIssuance | 4.52M | 0.00 | 8.55M | 1.43M |
| NetIssuancePaymentsOfDebt | 0.00 | -200.00K | -37.20K | 190.40K |
| NetShortTermDebtIssuance | 0.00 | -200.00K | -37.20K | 190.40K |
| ShortTermDebtPayments | 0.00 | -200.00K | -37.20K | -9.60K |
| ShortTermDebtIssuance | 0.00 | 200.00K | ||
| NetLongTermDebtIssuance | 0.00 | |||
| LongTermDebtPayments | 0.00 | |||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -577.54K | 4.45M | -6.79M | 0.00 |
| CashFlowFromContinuingInvestingActivities | -577.54K | 4.45M | -6.79M | 0.00 |
| NetInvestmentPurchaseAndSale | -407.23K | 4.66M | -6.79M | 0.00 |
| SaleOfInvestment | 33.22M | 41.28M | 0.00 | |
| PurchaseOfInvestment | -33.63M | -36.62M | -6.79M | 0.00 |
| NetBusinessPurchaseAndSale | 0.00 | -96.00K | 0.00 | |
| PurchaseOfBusiness | 0.00 | -96.00K | 0.00 | |
| NetIntangiblesPurchaseAndSale | -170.31K | -109.28K | 0.00 | |
| PurchaseOfIntangibles | -170.31K | -109.28K | 0.00 | |
| NetPPEPurchaseAndSale | 0.00 | |||
| PurchaseOfPPE | 0.00 | |||
| OperatingCashFlow | -3.94M | -3.84M | -2.22M | -1.08M |
| CashFlowFromContinuingOperatingActivities | -3.94M | -3.84M | -2.22M | -1.08M |
| ChangeInWorkingCapital | 121.65K | -768.86K | -634.07K | 522.64K |
| ChangeInOtherWorkingCapital | -130.00K | 130.00K | ||
| ChangeInOtherCurrentLiabilities | -4.46K | -50.80K | -46.03K | -36.97K |
| ChangeInPayablesAndAccruedExpense | 125.88K | -662.37K | -86.32K | 482.05K |
| ChangeInAccruedExpense | 129.46K | -163.54K | 99.11K | 99.41K |
| ChangeInPayable | -3.58K | -498.83K | -185.43K | 382.63K |
| ChangeInAccountPayable | -3.58K | -498.83K | -185.43K | 382.63K |
| ChangeInPrepaidAssets | 22.07K | -43.39K | -229.11K | -33.97K |
| ChangeInInventory | -18.16K | -7.81K | -142.85K | -8.75K |
| ChangeInReceivables | -3.67K | -4.49K | 253.00 | -9.70K |
| ChangesInAccountReceivables | -3.67K | -4.49K | 253.00 | -9.70K |
| OtherNonCashItems | 496.00 | 5.68K | -163.17K | |
| StockBasedCompensation | 3.56M | 2.41M | 270.67K | 4.48M |
| AssetImpairmentCharge | 0.00 | 5.76K | 31.07K | 0.00 |
| DepreciationAmortizationDepletion | 15.11K | 4.25K | 535.00 | 537.00 |
| DepreciationAndAmortization | 15.11K | 4.25K | 535.00 | 537.00 |
| AmortizationCashFlow | 15.11K | 3.75K | 0.00 | |
| AmortizationOfIntangibles | 15.11K | 3.75K | 0.00 | |
| Depreciation | 0.00 | 503.00 | 535.00 | 537.00 |
| OperatingGainsLosses | -34.97K | -846.88K | -22.92K | |
| EarningsLossesFromEquityInvestments | 95.14K | 0.00 | ||
| GainLossOnInvestmentSecurities | -130.11K | -231.88K | ||
| NetIncomeFromContinuingOperations | -7.61M | -4.65M | -1.70M | -6.08M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NXL
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|